PL327144A1 - Method of relieving paints - Google Patents

Method of relieving paints

Info

Publication number
PL327144A1
PL327144A1 PL96327144A PL32714496A PL327144A1 PL 327144 A1 PL327144 A1 PL 327144A1 PL 96327144 A PL96327144 A PL 96327144A PL 32714496 A PL32714496 A PL 32714496A PL 327144 A1 PL327144 A1 PL 327144A1
Authority
PL
Poland
Prior art keywords
paints
relieving
relieving paints
Prior art date
Application number
PL96327144A
Other languages
English (en)
Inventor
Charles Howard Mitch
Harlan Edgar Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL327144A1 publication Critical patent/PL327144A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
PL96327144A 1995-12-07 1996-12-05 Method of relieving paints PL327144A1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US830695P 1995-12-07 1995-12-07
US831895P 1995-12-07 1995-12-07
US829595P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US829895P 1995-12-07 1995-12-07
PCT/US1996/019390 WO1997020556A1 (en) 1995-12-07 1996-12-05 Method for treating pain

Publications (1)

Publication Number Publication Date
PL327144A1 true PL327144A1 (en) 1998-11-23

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96327144A PL327144A1 (en) 1995-12-07 1996-12-05 Method of relieving paints

Country Status (14)

Country Link
EP (1) EP0866702A4 (zh)
JP (1) JP2000501711A (zh)
KR (1) KR19990071977A (zh)
CN (1) CN1208348A (zh)
AU (1) AU715645B2 (zh)
CA (1) CA2239732A1 (zh)
CZ (1) CZ174598A3 (zh)
EA (1) EA199800535A1 (zh)
HU (1) HUP0000110A3 (zh)
IL (1) IL124786A0 (zh)
NO (1) NO982582L (zh)
NZ (1) NZ324594A (zh)
PL (1) PL327144A1 (zh)
WO (1) WO1997020556A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE248166T1 (de) 1999-06-04 2003-09-15 Lilly Co Eli 7-oxo-2-azabicyclo(2.2.1)heptane als selektive muskarin-rezeptor antagonisten
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
BR112021016457A2 (pt) * 2019-02-22 2021-10-13 Karuna Therapeutics, Inc. Composto, medicamento e método para tratar dor ou um distúrbio do sistema nervoso central em um paciente que precisa do mesmo
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
CN115974863A (zh) * 2021-10-14 2023-04-18 南京迈诺威医药科技有限公司 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Also Published As

Publication number Publication date
CZ174598A3 (cs) 1999-01-13
IL124786A0 (en) 1999-01-26
CN1208348A (zh) 1999-02-17
AU715645B2 (en) 2000-02-10
HUP0000110A2 (hu) 2000-06-28
EP0866702A4 (en) 2001-07-25
NO982582D0 (no) 1998-06-05
KR19990071977A (ko) 1999-09-27
EP0866702A1 (en) 1998-09-30
CA2239732A1 (en) 1997-06-12
NO982582L (no) 1998-08-03
HUP0000110A3 (en) 2000-09-28
EA199800535A1 (ru) 1998-12-24
WO1997020556A1 (en) 1997-06-12
JP2000501711A (ja) 2000-02-15
AU1147697A (en) 1997-06-27
NZ324594A (en) 1999-09-29

Similar Documents

Publication Publication Date Title
AU7379896A (en) Method and apparatus for improving the function of sensory cells
EP0831924A4 (en) METHOD FOR TREATING ASTHMA
AUPN271295A0 (en) Method of treatment
GB2308680B (en) Method of combining workpieces
GB2302523B (en) Method of printing
PL323236A1 (en) Method of obtaining lerkanipidin chlorchydride
PL324497A1 (en) Method of obtaining n-substituted 3-hydroxyparasoles
PL327144A1 (en) Method of relieving paints
PL313740A1 (en) Method of
HUP9900360A3 (en) Method of preparing norbenzomorphane-derivatives
AU1020997A (en) Method of treating sepsis
PL327147A1 (en) Method of obtaining dihydropyrimidinones
PL327197A1 (en) Method of obtaining pesticides
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
PL326978A1 (en) Method of obtaining dioxyaza bicyclohexanes
GB9507825D0 (en) Method of treatment
PL312826A1 (en) Method of obtaining dilthiazeme
PL323605A1 (en) Method of obtaining substituted 5-hydroxy-oxazolydin-4-ones
AU7349496A (en) Method for treatment of SLE
AU1829695A (en) Method of treatment of talc
GB9521681D0 (en) Improved method of manufacture
GB9516795D0 (en) Method of treatment
GB9508963D0 (en) Method of treatment
GB9502514D0 (en) Method of treatment
GB9500723D0 (en) Method of treatment